PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsClinuvel Pharmaceuticals
Clinuvel Pharmaceuticals(CUVL)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
ScenesseAfamelanotide2019-10-082025-2029
Erythropoietic protoporphyria
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Afamelanotide
healthy volunteers/patients
,
xeroderma pigmentosum
,
ichthyosis
,
urticaria
,
solar urticaria
,
squamous cell carcinoma
,
squamous cell neoplasms
,
organ transplantation
,
actinic keratosis
,
keratosis
,
ischemic stroke
,
stroke
,
ischemia
,
cerebral infarction
,
acne vulgaris
,
variegate porphyria
,
erythropoietic porphyria
,
porphyrias
,
erythropoietic protoporphyria
,
vitiligo
,
contact dermatitis
,
exanthema
Salicylic acid
onychomycosis
Nepidermin
breast neoplasms
,
carcinoma
,
head and neck neoplasms
,
squamous cell carcinoma of head and neck
,
non-small-cell lung carcinoma
,
neoplasm metastasis
,
myofascial pain syndromes
,
fibromyalgia
,
syndrome
,
hemangioma
,
port-wine stain
,
capillary hemangioma
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
melanoma
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use